Bright Minds Biosciences to Present at Upcoming Conferences

Bright Minds Biosciences Inc. (DRUG) — NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, Prader-Willi Syndrome, depression, and other central nervous system (CNS) disorders, today announced that the Company will present at the following upcoming conferences: EVENT:Cantor Global Healthcare Conference 2026 DATE:Wednesday, September 9,

Source: GlobeNewswire — read the full announcement there.

See our Bright Minds Biosciences company profile for background, links, and more Bright Minds Biosciences news.